| Specialty Retail Industry | Consumer Discretionary Sector | Dr. Sachin Dinesh Patel CChem., Ph.D. CEO | XNSE Exchange | Y8751R115 CUSIP |
| India Country | 1,702 Employees | 4 Sep 2025 Last Dividend | 10 Oct 2023 Last Split | - IPO Date |
Themis Medicare Limited operates in the pharmaceutical sector both in India and on an international level, engaging in the manufacturing and distribution of various pharmaceutical products. Initially founded as Themis Chemicals, the company underwent a rebranding to Themis Medicare Limited in 2001, marking a significant transition in its journey since its foundation in 1952. Based in Mumbai, India, Themis Medicare has expanded its operations to include a wide range of therapeutic domains, underlining its commitment to address diverse medical needs and contribute to global health and wellness.
Themis Medicare Limited boasts a comprehensive portfolio of pharmaceutical products and services designed to cater to a multitude of health care needs across different therapeutic areas. The company's offerings include: